The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.20
Bid: 131.80
Ask: 132.60
Change: 0.80 (0.61%)
Spread: 0.80 (0.607%)
Open: 135.00
High: 135.00
Low: 131.60
Prev. Close: 131.40
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Apr 2015 14:31

RNS Number : 8920L
NCC Group PLC
30 April 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART), DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY RESTRICTED JURISDICTION (INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICAAND NEW ZEALAND) OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Issue of equity

NCC Group plc ("NCC Group") confirms that, pursuant to the announcement by Accumuli plc ("Accumuli") earlier today that the scheme of arrangement under Part 26 of the Companies Act 2006 to effect the recommended acquisition of Accumuli by NCC Group has become effective, NCC Group has made applications to the UK Listing Authority ("UKLA") and London Stock Exchange plc ("London Stock Exchange") for 20,389,472 ordinary shares of 1 pence each in the capital of NCC Group (the "New Ordinary Shares") to be admitted to the premium listing segment of the Official List of the UKLA and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of these New Ordinary Shares will become effective, and that dealings on the London Stock Exchange will commence, on 1 May 2015.

Following the issuance of these New Ordinary Shares, NCC Group will have 229,076,580 ordinary shares of 1 pence each ("Ordinary Shares") with voting rights in issue (excluding treasury shares) and 238,186 treasury shares.

The above figure of 229,076,580 Ordinary Shares may be used by shareholders in NCC Group as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

Enquiries:

NCC Group

 

Rob Cotton, CEO

Atul Patel, Finance Director

Tel: +44 (0) 161 209 5251

Peel Hunt LLP (financial adviser and broker to NCC Group)

Charlie Batten / Richard Brown / Dan Webster

Tel: +44 (0)20 7418 8900

Rickitt Mitchell & Partners Limited (financial adviser to NCC Group)

Stuart Moss / Alex Wilson

Tel: +44 (0)161 834 0600

Instinctif Partners (PR to NCC Group)

Adrian Duffield / Lauren Foster / Chantal Woolcock

Tel: +44 (0)20 7457 2020

 

 

 

IMPORTANT NOTES

Cautionary note regarding forward-looking statements

This Announcement contains certain forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'hope', 'aims', 'continue', 'will', 'may', 'should', 'would', 'could' or other words of similar meaning. These statements are based on assumptions and assessments made by the Board of NCC Group in light of its experience and its perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate. By their nature, forward-looking statements involve risk and uncertainty and the factors described in the context of such forward-looking statements in this Announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements.

Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this Announcement are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this Announcement. NCC Group assumes no obligation to update or correct the information contained in this Announcement (whether as a result of new information, future events or otherwise), except as required by applicable law.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEWGURPCUPAGWU
Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.